Spineway Zockerwert oder doch Perspektive? (Seite 177)
eröffnet am 11.02.21 10:54:55 von
neuester Beitrag 04.06.24 10:05:10 von
neuester Beitrag 04.06.24 10:05:10 von
Beiträge: 1.777
ID: 1.341.947
ID: 1.341.947
Aufrufe heute: 1
Gesamt: 225.480
Gesamt: 225.480
Aktive User: 0
ISIN: FR001400N2P2 · WKN: A400E3
0,7350
EUR
-5,89 %
-0,0460 EUR
Letzter Kurs 20.06.24 Lang & Schwarz
Neuigkeiten
| TitelBeiträge |
|---|
04.03.24 · Markus Weingran  |
30.01.24 · Markus Weingran |
Werte aus der Branche Gesundheitswesen
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,1300 | +145,49 | |
| 2,6300 | +143,07 | |
| 0,6500 | +38,30 | |
| 1,2700 | +32,98 | |
| 4,8500 | +28,99 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,3988 | -15,48 | |
| 1,0000 | -16,67 | |
| 4,5800 | -18,94 | |
| 2,0100 | -29,47 | |
| 2,00 | -60,00 |
Beitrag zu dieser Diskussion schreiben
Feedback
February 11, 2021 12:40 ET
Spineway Expansion in Asia
Press release Ecully, February 11th, 2021 – 6:30 p.m.
Continued expansion in Asia :
First implantation of the Mont Blanc 3D+ in Thailand
Signature of an Exclusive Distribution Agreement in Malaysia
Spineway, specialized in the treatment of severe disorders of the spine, announces the first surgery in Thailand with Mont Blanc 3D+ instrumentation as well as the signature of an exclusive distribution agreement for the marketing of its products in Malaysia.
This operation was successfully performed on February 4th, 2021 by Dr Chatchawarl Sarntipiphat, orthopedic surgeon at Srinagarind University Hospital in Khon Kaen Province, Thailand, on an 11-year-old patient with idiopathic scoliosis.
Doctor Sarntipiphat specifies the context of this operation : “This type of scoliosis requires a surgical correction because the permanent deviation of the spine can cause a deformation of the vertebral bodies, especially during the child's growth period. Particularly indicated for this type of pathology, Spineway's patented Mont Blanc 3D+ implant makes it possible to correct the deformity while keeping the natural curves of the spine.”
Present in Thailand since 2016 through exclusive distribution, Spineway continues to develop its know-how on the Asian continent with the implementation of a national distribution agreement within the main healthcare centers in Malaysia, a few months after the signing of an exclusive commercial agreement for the sale of its products in Japan1. Spineway and its partner will promote and introduce the whole product portfolio, in particular, the specific solutions for mini-invasive surgery Mont-Blanc MIS.
Stéphane Le Roux, CEO of Spineway, says : “We are delighted with this partnership in Malaysia, a country recognized as having one of the best healthcare systems in Asia. Our Mont-Blanc MIS and MISTI platform designed by Spineway will address the market needs by providing advanced surgical techniques to surgeons and patients”.
Sales are scheduled to start in June 2020, immediately after the product registration will be granted by the Medical Device Authority in Malaysia.
This first implantation of the Mont Blanc 3D+ in Thailand and this new distribution agreement in Malaysia demonstrate that Spineway continues its development in Asia thanks to the high added value of its technologies.
Upcoming: April 15th, 2021 - Publication of first quarter 2021 revenues
March 8th, 2021 – General meeting
The annual accounts and and the preparatory documents for the Shareholders' Meeting
are available on the company’s website in the Investors
SPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLANS FOR SMES)
Find out all about Spineway at www.spineway.com
This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.
Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports.
Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation award (2013) – INPI Talent award (2015).
ISIN: FR0011398874 - ALSPW
Quelle: Globenewswire.com
Spineway Expansion in Asia
Press release Ecully, February 11th, 2021 – 6:30 p.m.
Continued expansion in Asia :
First implantation of the Mont Blanc 3D+ in Thailand
Signature of an Exclusive Distribution Agreement in Malaysia
Spineway, specialized in the treatment of severe disorders of the spine, announces the first surgery in Thailand with Mont Blanc 3D+ instrumentation as well as the signature of an exclusive distribution agreement for the marketing of its products in Malaysia.
This operation was successfully performed on February 4th, 2021 by Dr Chatchawarl Sarntipiphat, orthopedic surgeon at Srinagarind University Hospital in Khon Kaen Province, Thailand, on an 11-year-old patient with idiopathic scoliosis.
Doctor Sarntipiphat specifies the context of this operation : “This type of scoliosis requires a surgical correction because the permanent deviation of the spine can cause a deformation of the vertebral bodies, especially during the child's growth period. Particularly indicated for this type of pathology, Spineway's patented Mont Blanc 3D+ implant makes it possible to correct the deformity while keeping the natural curves of the spine.”
Present in Thailand since 2016 through exclusive distribution, Spineway continues to develop its know-how on the Asian continent with the implementation of a national distribution agreement within the main healthcare centers in Malaysia, a few months after the signing of an exclusive commercial agreement for the sale of its products in Japan1. Spineway and its partner will promote and introduce the whole product portfolio, in particular, the specific solutions for mini-invasive surgery Mont-Blanc MIS.
Stéphane Le Roux, CEO of Spineway, says : “We are delighted with this partnership in Malaysia, a country recognized as having one of the best healthcare systems in Asia. Our Mont-Blanc MIS and MISTI platform designed by Spineway will address the market needs by providing advanced surgical techniques to surgeons and patients”.
Sales are scheduled to start in June 2020, immediately after the product registration will be granted by the Medical Device Authority in Malaysia.
This first implantation of the Mont Blanc 3D+ in Thailand and this new distribution agreement in Malaysia demonstrate that Spineway continues its development in Asia thanks to the high added value of its technologies.
Upcoming: April 15th, 2021 - Publication of first quarter 2021 revenues
March 8th, 2021 – General meeting
The annual accounts and and the preparatory documents for the Shareholders' Meeting
are available on the company’s website in the Investors
SPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLANS FOR SMES)
Find out all about Spineway at www.spineway.com
This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.
Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports.
Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation award (2013) – INPI Talent award (2015).
ISIN: FR0011398874 - ALSPW
Quelle: Globenewswire.com
was zu henker.. hab mit restgeld 200k anteile gekauft. und heute... boom, hype. ich hoffe es ist nachhaltig und kein jump and dump. euch alles viel erfolg mit dieser aktie.
So schnell war ich noch nie im plus
Scheint gut im Hype zu sein ...
Mal sehen was daraus wird 🤑
Mal sehen was daraus wird 🤑
Trading Spotlight
Hab es zufällig beim Broker gesehen und dass ein Analyst den Kurs auf 0,01 Cent bewertet hat. Hab mich mal eingekauft mit Restgeld. Keine Ahnung was die Firma macht oder tut ehrlich gesagt 😅
wurde nur in einen forum erwähnt in facebook homepage sieht gut gestaltet und übersichtlich aus mal schaun was passiert hatte letzte jahr auch so teil hashchain wo danach sich im eurobereich befand
Ich habe gelesen, dass das Unternehmen auch zahlreiche Patente besitzt und sich neu strukturiert hat. Des Weiteren haben sich die Zahlen durch Personaleinsparungen deutlich verbessert. Die OP Zunahme klingt ebenfalls plausibel. Allerdings schwächelte die Aktie auch schon stark gegen null vor Corona.
letzte news war am 28.feb 2020 nur a trainingsschulungsprogramm für ärtze u medizinisches personal
denke die spekulationen verdichten sich das nach corona die ganzen verschobenen op s nachgeholt werden haben recht viele stands in ihren programm auf homepage spineway.com habe ich no keine aktuelle news no nicht gefunden insider!!! von den gebühren must schon im einstelligen millionenbereich kaufen damit sich die anschaffungskosten rentieren
Durchsuchen
